openPR Logo
Press release

EpiCast Report: Acute Myeloid Leukemia - Epidemiology Forecast to 2026

07-28-2017 03:30 PM CET | Health & Medicine

Press release from: Acute Myeloid Leukemia

EpiCast Report: Acute Myeloid Leukemia - Epidemiology Forecast

Albany, New York, July 28, 2017 : Recent research and the current scenario as well as future market potential of " Development of Acute Myeloid Leukemia - Epidemiology Forecast to 2026 : Trends and Application 2017 " globally.

Acute myeloid leukemia (AML) is a rare cancer that accounts for a disproportionally high number of cancer-related deaths. The disease is more common in the elderly, and is relatively more common in men than in women. AML progresses quickly, has low survival rates, and has high rates of relapse, even with treatment. The cause of AML is unknown, but an increased risk of the disease is associated with factors such as age, male sex, a history of smoking, and exposure to high doses of radiation and cytotoxic chemicals. Due to the rarity of the disease, the relationships between most risk factors and the disease have not been strongly established through epidemiological studies.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=1256665

In 2016, the 7MM had 43,592 diagnosed incident cases of AML. This is expected to increase to 52,526 diagnosed incident cases of AML by 2026, at an Annual Growth Rate (AGR) of 2.05%. The increase is driven by the aging population in the 7MM. In 2016, the 7MM had 57,581 five-year diagnosed prevalent cases of AML. This is expected to increase to 66,743 by 2026, at an AGR of 1.54%. The US had the highest number of diagnosed incident and five-year prevalent cases of AML. The development of more effective therapies, particularly for elderly patients, would improve survival and increase disease prevalence.

The use of a consistent methodology across the 7MM to forecast the diagnosed incident cases and the diagnosed five-year prevalent cases of AML allows for a meaningful comparison of the forecast incident cases and the forecast five-year prevalent cases of AML in these markets. Additionally, GlobalData epidemiologists provide a detailed segmentation of the diagnosed incident and five-year diagnosed prevalent cases of AML by subtypes and risk group classification, which are both important factors for predicting the prognosis in patients as well as specific treatment modalities for AML. Finally, this report reflects numerous updates to the AML literature, including more up-to-date, country-specific AML incidence rates, the impact of coding differences on incidence, and more up-to-date relative survival rates.

Scope

- The Acute Myeloid Leukemia (AML) EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of AML in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the following segmentations in ages 18 years and older across the 7MM: diagnosed incident cases of AML, segmented by ages 18-59 years and ages 60 years and older; five-year diagnosed prevalent cases of AML, segmented by ages 18-59 years and ages 60 years and older; diagnosed incident cases of (acute promyelocytic leukemia) APL and secondary AML, segmented by ages 18-59 years and ages 60 years and older; diagnosed incident cases of AML with mutations (FLT3-ITD [internal tandem duplications], FLT3-TKD [tyrosine kinase domain], IDH [isocitrate dehydrogenase] 1 and IDH2), core binding factor (CBF) AML with KIT mutation, and biomarker CD33+; and diagnosed incident cases of AML classified into favorable-, intermediate-, and adverse-risk groups.
- The AML epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The AML EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global AML market.
- Quantify patient populations in the global AML market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for AML therapeutics in each of the markets covered.
- Identify the percentage of AML diagnosed incident and five-year diagnosed prevalent cases by various clinical segmentations.

Make an Enquiry about TOC @ http://www.researchmoz.us/epicast-report-acute-myeloid-leukemia-epidemiology-forecast-to-2026-report.html

Table of Contents

1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3

2 Acute Myeloid Leukemia: Executive Summary 4
2.1 Related Reports 6
2.2 Upcoming Reports 7

3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and Comorbidities 9
3.3 Global and Historical Trends 10
3.3.1 Incidence 10
3.3.2 Relative Survival 12

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
90 State Street,
Albany, NY 12207,
United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release EpiCast Report: Acute Myeloid Leukemia - Epidemiology Forecast to 2026 here

News-ID: 646782 • Views:

More Releases for AML

Anti Money Laundering (AML) Software Market Competitive Landscape Data Along Wit …
The study on the Global Anti Money Laundering (AML) Software Market presents a holistic evaluation of various end-use industries, market scenario, and historic trends. With help of extensive primary and secondary research, research authors predict the changing market dynamics in the market during the forecast period of 2021 to 2027. The research on the Global Anti Money Laundering (AML) Software Market provides valuable insights about evaluation of consumer purchasing behavior
ALSEGO’s New Automated AML Reporting Solution for Luxembourgish Banks
ALSEGO has launched a new automated AML Reporting solution aimed specifically at financial institutions in Luxembourg concerned with the Central Electronic Data Retrieval System (CEDRS) as stipulated in the CSSF circular 20/747. The solution is fully automated, however, if you wish to forgo a direct connection between the solution and your core-banking system, the solution functions with TSV/CSV files as well. The automatic functionalities of the solution are its key strengths.
AML Software Market to Grow with a High CAGR
[160 Pages Report] PMI's publication of the AML Software Market-Size, Share, Trends, forecast 2030 examines the market for AML Software and the considerations involved in implementation. The 66-page report reviews the growing market for AML Software, plus the latest trends, opportunities and challenges. In this report you will learn: Who the leading players are in AML Software What you should look for in a AML Software solution What trends are driving the adoption About the
Global AML Software Market Size, Status and Forecast
AML software is software used in the finance and legal industries to meet the legal requirements for financial institutions and other regulated entities to prevent or report money laundering activities. Europe to be the largest market for AML software during the forecast period. Though the Europe accounts for the largest market share, the APAC region is envisaged to witness the fastest growth during the predicted period. United States will still
Global Anti-money Laundering Software Market 2015 | Major Key Players : ACI Worl …
Description : Technavio’s market research analyst predicts the global anti-money laundering (AML) software market to grow steadily at a CAGR of around 11% during the forecast period. AML software allows financial institutions and other enterprises to detect suspicious transactions and analyze customer data. Its ability to provide real-time alerts and tools to report suspicious events to maximize security and operational efficiency will foster its adoption during the forecast period. An important growth
Anti-money Laundering Software Global Market 2018: Key Players – ACI Worldwide …
Anti-money Laundering Software Industry Description Wiseguyreports.Com Adds “Anti-money Laundering Software -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database This report studies Anti-money Laundering Software in Global market, especially in North America, Europe, China, Japan, Korea and Taiwan, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering ACI Worldwide AML360 AML Partners AML RightSource BAE EastNets Experian